Skip to main content
. 2015 Apr 27;112(19):6140–6145. doi: 10.1073/pnas.1417320112

Table 1.

Patient characteristics

Variable Value (%)
Mean age, y 62
Sex
 Male 21 (72)
 Female 8 (28)
ECOG performance status
 0 17 (59)
 1 12 (41)
M stage
 M1a 2 (7)
 M1b 6 (21)
 M1c 21 (72)
Prior lines of systemic therapy for metastatic disease
1 28 (97)
2 1 (3)
Ipilimumab cycles
 4 23 (79)
 3 3 (10)
 2 3 (10)
 1 0

ECOG, Eastern Cooperative Oncology Group.